Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394–424.
Keaver L, Xu B, Jaccard A, Webber L. Morbid obesity in the UK: a modelling projection study to 2035. Scand J Public Health. 2020;48:422–7.
Crosbie EJ, Zwahlen M, Kitchener HC, Egger M, Renehan AG. Body mass index, hormone replacement therapy, and endometrial cancer risk: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19:3119–30.
Article CAS PubMed Google Scholar
Weihe P, Spielmann J, Kielstein H, Henning-Klusmann J, Weihrauch-Blüher S. Childhood obesity and cancer risk in adulthood. Curr Obes Rep. 2020;9:204–12.
Aarestrup J, Gamborg M, Ulrich LG, Sørensen TIA, Baker JL. Childhood body mass index and height and risk of histologic subtypes of endometrial cancer. Int J Obes. 2016;40:1096–102.
von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–9.
Smith GD, Ebrahim S. ‘Mendelian randomization’: can genetic epidemiology contribute to understanding environmental determinants of disease? Int. J. Epidemiol. 2003;32:1–22.
Burgess S, Thompson SG. Multivariable Mendelian randomization: the use of pleiotropic genetic variants to estimate causal effects. Am J Epidemiol. 2015;181:251–60.
Article PubMed PubMed Central Google Scholar
Richardson TG, Sanderson E, Elsworth B, Tilling K, Davey Smith G. Use of genetic variation to separate the effects of early and later life adiposity on disease risk: mendelian randomisation study. BMJ. 2020;369:m1203.
Article PubMed PubMed Central Google Scholar
O’Mara TA, Glubb DM, Amant F, Annibali D, Ashton K, Attia J, et al. Identification of nine new susceptibility loci for endometrial cancer. Nat Commun. 2018;9:3166.
Article PubMed PubMed Central Google Scholar
Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512–25.
Article PubMed PubMed Central Google Scholar
Bowden J, Davey, Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with Some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304–14.
Article PubMed PubMed Central Google Scholar
Hartwig FP, Davey Smith G, Bowden J. Robust inference in summary data Mendelian randomization via the zero modal pleiotropy assumption. Int J Epidemiol. 2017;46:1985–98.
Article PubMed PubMed Central Google Scholar
Hemani G, Bowden J, Davey Smith G. Evaluating the potential role of pleiotropy in Mendelian randomization studies. Hum Mol Genet. 2018;27:R195–R208.
Article CAS PubMed PubMed Central Google Scholar
Hemani G, Zheng J, Elsworth B, Wade KH, Haberland V, Baird D, et al. The MR-Base platform supports systematic causal inference across the human phenome. Elife. 2018;7:e34408 https://doi.org/10.7554/eLife.34408
Article PubMed PubMed Central Google Scholar
Yavorska OO, Burgess S. MendelianRandomization: an R package for performing Mendelian randomization analyses using summarized data. Int J Epidemiol. 2017;46:1734–9.
Article PubMed PubMed Central Google Scholar
Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1–48.
Burgess S, Davies NM, Thompson SG. Bias due to participant overlap in two-sample Mendelian randomization. Genet Epidemiol. 2016;40:597–608.
Article PubMed PubMed Central Google Scholar
Mahdy H, Casey MJ, Crotzer D. Endometrial cancer. StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. https://www.ncbi.nlm.nih.gov/books/NBK525981/.
Ogden CL, Carroll MD, Curtin LR, Lamb MM, Flegal KM. Prevalence of high body mass index in US children and adolescents, 2007–2008. JAMA. 2010;303:242–9.
Article CAS PubMed Google Scholar
Jaishuen A, Kunakornporamat K, Viriyapak B, Benjapibal M, Chaopotong P, Petsuksiri J, et al. Incidence and clinical outcomes of non-endometrioid carcinoma of endometrium: Siriraj Hospital experience. Asian Pac J Cancer Prev. 2014;15:2905–9.
Painter JN, O’Mara TA, Marquart L, Webb PM, Attia J, Medland SE, et al. Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer. Cancer Epidemiol Biomarkers Prev. 2016;25:1503–10.
Article PubMed PubMed Central Google Scholar
Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev. 2002;11:1531–43.
Mesa Valencia DC, Mericq V, Corvalán C, Pereira A. Obesity and related metabolic biomarkers and its association with serum levels of estrogen in pre-pubertal Chilean girls. Endocr Res. 2020;45:102–10.
Article CAS PubMed Google Scholar
Tobin LM, Mavinkurve M, Carolan E, Kinlen D, O’Brien EC, Little MA, et al. NK cells in childhood obesity are activated, metabolically stressed, and functionally deficient. JCI insight. 2017;2. https://doi.org/10.1172/jci.insight.94939.
留言 (0)